Clinical Effect of Compound Xueshuantong Capsule on Patients With Glaucoma Optic Nerve Atrophy
Objective To analyze the clinical advantages of compound Xueshuantong capsule in the clinical treatment of patients with glaucoma optic nerve atrophy.Methods A total of 70 patients diagnosed with optic nerve atrophy due to glaucoma in Yankuang New Journey General Hospital from January 2022 to January 2023 were selected.The patients were randomly divided into control group and study group,35 cases each.The control group received conventional treatment,and the study group added compound Xueshuantong capsule to the conventional drug treatment.The clinical therapeutic effect of the two groups was compared.Results After 40 d of treatment,the visual acuity level,light sensitivity and defect degree of the study group were higher than those of the control group,and the total gray value was lower than that of the control group(P<0.05).The end-diastolic blood flow velocity and peak systolic flow velocity of the study group were higher than those of the control group,and the resistance index and pulse index of the study group were lower than those of the control group(P<0.05).The total effective rate of the study group was 96.00%,higher than 76.00%of the control group(P<0.05).Conclusion The combination of conventional western medicine and compound Xueshuantong capsule in the treatment of glaucoma optic nerve atrophy can improve the visual acuity level and ocular hemodynamic index,improve the overall treatment effectiveness,and have high application value.
万方数据
维普
